Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Exp Cell Res
    March 2018
  1. LI K, Yan H, Guo W, Tang M, et al
    ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.
    Exp Cell Res. 2018 Mar 6. pii: S0014-4827(18)30125.
    >> Share

  2. YAMASHITA N, Saito N, Zhao S, Terai K, et al
    Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.
    Exp Cell Res. 2018 Mar 1. pii: S0014-4827(18)30116.
    >> Share

    January 2018
  3. MOREIRA MP, da Conceicao Braga L, Cassali GD, Silva LM, et al
    STAT3 as a promising chemoresistance biomarker associated with the CD44(+/high)/CD24(-/low)/ALDH(+) BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line.
    Exp Cell Res. 2018 Jan 15. pii: S0014-4827(18)30027.
    >> Share

  4. HUANG Y, Yang L, Pei YY, Wang J, et al
    Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway.
    Exp Cell Res. 2018 Jan 4. pii: S0014-4827(18)30003.
    >> Share

  5. LUO CW, Wu CC, Chang SJ, Chang TM, et al
    CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Exp Cell Res. 2018 Jan 3. pii: S0014-4827(17)30695.
    >> Share

    December 2017
  6. GONG XF, Yu AL, Tang J, Wang CL, et al
    MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30640.
    >> Share

    November 2017
  7. LO JH, Chen TT
    Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231).
    Exp Cell Res. 2017 Nov 27. pii: S0014-4827(17)30628.
    >> Share

    October 2017
  8. ZHU S, Wang X, Wang J, Lin J, et al
    CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
    Exp Cell Res. 2017 Oct 17. pii: S0014-4827(17)30561.
    >> Share

  9. DE S, Das S, Mukherjee S, Das S, et al
    Establishment of Twist-1 and TGFBR2 as direct targets of microRNA-20a in Mesenchymal to Epithelial Transition of Breast Cancer Cell-line MDA-MB-231.
    Exp Cell Res. 2017 Oct 4. pii: S0014-4827(17)30532.
    >> Share

    September 2017
  10. CASCIONE M, De Matteis V, Toma CC, Pellegrino P, et al
    Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
    Exp Cell Res. 2017 Sep 19. pii: S0014-4827(17)30500.
    >> Share

    August 2017
  11. HOU MF, Luo CW, Chang TM, Hung WC, et al
    The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Exp Cell Res. 2017 Aug 24. pii: S0014-4827(17)30450.
    >> Share

  12. YAN N, Xu L, Wu X, Zhang L, et al
    GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Exp Cell Res. 2017 Aug 18. pii: S0014-4827(17)30435.
    >> Share

  13. XIANG Y, Liao XH, Yao A, Qin H, et al
    MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
    Exp Cell Res. 2017 Aug 17. pii: S0014-4827(17)30434.
    >> Share

    July 2017
  14. TVEITARAS MK, Reigstad I, Leiss L, Reed RK, et al
    Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
    Exp Cell Res. 2017 Jul 19. pii: S0014-4827(17)30393.
    >> Share

  15. SMUCZEK B, Santos ES, Siqueira AS, Pinheiro JJV, et al
    The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
    Exp Cell Res. 2017 Jul 5. pii: S0014-4827(17)30359.
    >> Share

    May 2017
  16. YI Z, Yang D, Liao X, Guo F, et al
    PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer.
    Exp Cell Res. 2017 May 18. pii: S0014-4827(17)30296.
    >> Share

  17. XIANG Y, Liao XH, Yu CX, Yao A, et al
    MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
    Exp Cell Res. 2017 May 9. pii: S0014-4827(17)30272.
    >> Share

  18. XIE D, Liu Z, Wu J, Feng W, et al
    The effects of activin A on the migration of human breast cancer cells and neutrophils and their migratory interaction.
    Exp Cell Res. 2017 May 4. pii: S0014-4827(17)30267.
    >> Share

  19. PERRI M, Caroleo MC, Liu N, Gallelli L, et al
    9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models.
    Exp Cell Res. 2017;354:25-30.
    >> Share

    March 2017
  20. PATEL BB, Ackerstaff E, Serganova IS, Kerrigan JE, et al
    Tumor stroma interaction is mediated by monocarboxylate metabolism.
    Exp Cell Res. 2017;352:20-33.
    >> Share

    February 2017
  21. GKRETSI V, Stylianou A, Stylianopoulos T
    Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, beta-catenin and urokinase-plasminogen activator (uPA).
    Exp Cell Res. 2017 Feb 13. pii: S0014-4827(17)30064.
    >> Share

    December 2016
  22. DHO SH, Kim JY, Lee KP, Kwon ES, et al
    STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells.
    Exp Cell Res. 2016 Dec 26. pii: S0014-4827(16)30434.
    >> Share

  23. IRAVANI O, Bay BH, Yip GW
    Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1.
    Exp Cell Res. 2016 Dec 23. pii: S0014-4827(16)30428.
    >> Share

    November 2016
  24. CEPEDA MA, Pelling JJ, Evered CL, Leong HS, et al
    The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells.
    Exp Cell Res. 2016 Nov 23. pii: S0014-4827(16)30391.
    >> Share

    September 2016
  25. ALIMIRAH F, Peng X, Gupta A, Yuan L, et al
    Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
    Exp Cell Res. 2016 Sep 27. pii: S0014-4827(16)30243.
    >> Share

    August 2016
  26. RADDE BN, Ivanova MM, Mai HX, Alizadeh-Rad N, et al
    Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
    Exp Cell Res. 2016 Aug 8. pii: S0014-4827(16)30235.
    >> Share

    July 2016
  27. SENGUPTA D, Deb M, Rath SK, Kar S, et al
    DNA methylation and not H3K4trimethylation dictates the expression status of miR-152gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Exp Cell Res. 2016 Jul 27. pii: S0014-4827(16)30211.
    >> Share

    May 2016
  28. DINICOLA S, Fabrizi G, Masiello MG, Proietti S, et al
    Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
    Exp Cell Res. 2016 May 26. pii: S0014-4827(16)30111.
    >> Share

  29. DODDAPANENI R, Patel K, Chowdhury N, Singh M, et al
    Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Exp Cell Res. 2016 May 10. pii: S0014-4827(16)30110.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016